Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2007
10/10/2007EP1841767A1 Pyrazolopyridines, their preparation and their medical use
10/10/2007EP1841766A1 Pyrrolopyridines useful in the treatment of inflammation
10/10/2007EP1841760A2 Pyrimidine derivatives as kinase modulators and method of use
10/10/2007EP1841755A1 Substituted indole ligands for the orl-1 receptor
10/10/2007EP1841746A1 Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of cns disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates
10/10/2007EP1841743A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841742A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841737A1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/10/2007EP1841736A1 Indoles useful in the treatment of inflammation
10/10/2007EP1841735A1 Indoles useful in the treatment of inflammation
10/10/2007EP1841459A2 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain
10/10/2007EP1841439A1 Compositions comprising extracts from sanguinaria or macleaya
10/10/2007EP1841423A2 Use of 1- benzyl-1- hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3 hydroxy-2-amino propionic acid amides and related compounds as analgesics
10/10/2007EP1610792B1 Calcium channel blockers comprising two benzhydril moieties
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1503746B1 Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1404295B1 Sustained release drug delivery devices with coated drug cores
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1249450B1 Benzimidazole derivatives as human chymase inhibitors
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1173195B1 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/10/2007EP1154764B1 Use of epoxide hydrolase complexes for treating hypertension
10/10/2007CN101052638A 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
10/10/2007CN101052627A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
10/10/2007CN101052623A Phenanthridine carbonyl phenols as cytokine modulators
10/10/2007CN101052421A Phospholipase enzymes c-ªå regulating and its application for controlling pain and injury effect
10/10/2007CN101052401A Use of unsaturated quionoline or naphtalene derivatives as medicaments
10/10/2007CN101050193A Nitric ester derivatives, its medicinal composition and their medicinal use
10/10/2007CN101050170A New type natural active compound for anti tumor, preparation method, and application
10/10/2007CN101049485A Mulberry ¿C ginger soft capsule for treating common cold, and preparation method
10/10/2007CN101049457A Composition of Chinese traditional medicine for treating rheumatism
10/10/2007CN101049442A Preparation of Chinese traditional medicine of clearing away heat and promoting diuresis, promoting blood circulation and activating the channels, and preparation method
10/10/2007CN101049437A External ointment for treating numbness and ache of cold dampness
10/10/2007CN101049387A Composition of Chinese traditional medicine for treating rheumatic bone disease
10/10/2007CN101049352A Method for preparing short-pedicel aconite root of Chinese traditional medicine
10/10/2007CN101049351A Composition of Chinese traditional medicine for treating prolapse of lumbar intervertebral disc
10/10/2007CN101049328A Technique for producing extractive of olive growing leaves
10/10/2007CN101049327A Application of gambogicacid in preparing medication for restraining angiogenesis
10/10/2007CN101049320A Buccal tablets of extractive of propolis alcohol
10/10/2007CN101049310A Nerve block injection, and preparation technique
10/10/2007CN101049296A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
10/10/2007CN101049291A Buluoweima drop pills, and preparation method
10/10/2007CN101049174A Protein beverage of kernel of mongolian snakegourd
10/10/2007CN100341876C Spiro-substituted pyrrolopyrimidines
10/10/2007CN100341557C Externally applied plaster
10/10/2007CN100341553C External application medicine for treating appendicitis, and its prepn. method
10/10/2007CN100341540C Angelica root mistletoe granules and its preparation method
10/10/2007CN100341537C Composition for treatment of B-type hepatitis and liver cirrhosis
10/10/2007CN100341529C Combination of Tibet medicine of containing salt and possessing medicinal effect health care, and preparation metohd
10/10/2007CN100341528C Use of manchurian tuber gourd fruit extract for preparing analgesic, anti-inflammatory and/or anti-allergic medicine
10/10/2007CN100341498C Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/10/2007CN100341493C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/10/2007CA2564435A1 Methods for monitoring and treating intestinal disorders
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279560 Administering monoclonal antibodies to inhibit transmission of costimulatory signal of lymphocytes; antiallergens; autoimmune diseases
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279498 Substituted aryl amides as IP antagonists
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279484 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279175 Reduce restenosis coating on medical device
10/09/2007US7279158 Methods for the treatment of inflammatory joint disease
10/09/2007CA2252084C Cytoprotective compounds
10/09/2007CA2232855C Pharmaceutical formulation
10/05/2007CA2646021A1 O-glycans in the treatment of inflammatory bowel disease and cancers
10/04/2007WO2007112000A2 Treatment of pain
10/04/2007WO2007111350A1 Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111038A1 Aggrecanase production inhibitor
10/04/2007WO2007110380A1 Insect bite relief preparation comprising epinastine
10/04/2007WO2007109844A1 Anti-inflammatory metal complexes
10/04/2007WO2007109843A1 Metal complexes having anti-inflammatory activity
10/04/2007WO2007095615A3 Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007WO2007072163A3 Pyrimidine derivatives
10/04/2007WO2007067581A8 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
10/04/2007WO2007031879A3 Lipid a analogs for treating oral and gastrointestinal mucositis
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007US20070232692 Method of Treating Cancer Using Dithiocarbamate Derivatives
10/04/2007US20070232651 Novel anabaseine derivatives, pharmaceutical compositions and methods of use thereof
10/04/2007US20070232636 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, COPD and micturition disorders such as urinary incontinence
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232559 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
1 ... 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 ... 1272